154 related articles for article (PubMed ID: 3946922)
1. The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects.
Dunn TL; Gerber MJ; Shen AS; Fernandez E; Iseman MD; Cherniack RM
Am Rev Respir Dis; 1986 Feb; 133(2):264-8. PubMed ID: 3946922
[TBL] [Abstract][Full Text] [Related]
2. Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.
Bauer KG; Brunner-Ferber F; Distlerath LM; Lippa EA; Binkowitz B; Till P; Kaik GA
Br J Clin Pharmacol; 1992 Aug; 34(2):122-9. PubMed ID: 1358158
[TBL] [Abstract][Full Text] [Related]
3. Unsuspected bronchospasm in association with topical timolol--a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement?
Diggory P; Heyworth P; Chau G; McKenzie S; Sharma A
Age Ageing; 1994 Jan; 23(1):17-21. PubMed ID: 8010165
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
Schoene RB; Abuan T; Ward RL; Beasley CH
Am J Ophthalmol; 1984 Jan; 97(1):86-92. PubMed ID: 6141730
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary effects of topical timolol.
Charan NB; Lakshminarayan S
Arch Intern Med; 1980 Jun; 140(6):843-4. PubMed ID: 7387281
[TBL] [Abstract][Full Text] [Related]
6. Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients.
Diggory P; Heyworth P; Chau G; McKenzie S; Sharma A; Luke I
Eye (Lond); 1993; 7 ( Pt 5)():661-3. PubMed ID: 8287989
[TBL] [Abstract][Full Text] [Related]
7. Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Yamada Y; Takayanagi R; Tsuchiya K; Ito K; Ohtani H; Sawada Y; Iga T
J Ocul Pharmacol Ther; 2001 Jun; 17(3):235-48. PubMed ID: 11436944
[TBL] [Abstract][Full Text] [Related]
8. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
[No Abstract] [Full Text] [Related]
9. Preventive effect of lacrimal occlusion on topical timolol-induced bronchoconstriction in asthmatics.
Hepsen IF; Yildirim Z; Yilmaz H; Kotuk M
Clin Exp Ophthalmol; 2004 Dec; 32(6):597-602. PubMed ID: 15575830
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
Bleckmann H; Dorow P
Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ophthalmic beta-blocking agents.
Lesar TS
Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
[TBL] [Abstract][Full Text] [Related]
13. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Diggory P; Cassels-Brown A; Fernandez C
Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
[TBL] [Abstract][Full Text] [Related]
14. [Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].
Le Jeunne C; Munera Y; Teillet L; Hugues FC
Allerg Immunol (Paris); 1988 Sep; 20(7):267-9. PubMed ID: 2902862
[TBL] [Abstract][Full Text] [Related]
15. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
[TBL] [Abstract][Full Text] [Related]
16. Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity.
Weissman SS; Asbell PA
Br J Ophthalmol; 1990 Jul; 74(7):409-12. PubMed ID: 2378856
[TBL] [Abstract][Full Text] [Related]
17. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents.
Diggory P; Cassels-Brown A; Vail A; Abbey LM; Hillman JS
Lancet; 1995 Jun; 345(8965):1604-6. PubMed ID: 7646670
[TBL] [Abstract][Full Text] [Related]
18. Betaxolol eye drops. A clinical trial of safety and efficacy.
Goldberg I; Goldberg H
Aust N Z J Ophthalmol; 1995 Feb; 23(1):17-24. PubMed ID: 7619450
[TBL] [Abstract][Full Text] [Related]
19. Long-term betaxolol therapy in glaucoma patients with pulmonary disease.
Weinreb RN; van Buskirk EM; Cherniack R; Drake MM
Am J Ophthalmol; 1988 Aug; 106(2):162-7. PubMed ID: 3400758
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the airway response to eye drops of timolol and its isomer L-714,465 in asthmatic subjects.
Richards R; Tattersfield AE
Br J Clin Pharmacol; 1987 Oct; 24(4):485-91. PubMed ID: 2961362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
